A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...

Using the microscopic structures found on the wings of the Morpho butterfly, researchers have developed a simple and inexpensive way to analyze cancer biopsy samples that could make cancer diagnosis ...

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder.

Researchers at the University of California San Diego have found an unusual ally in the quest to make cancer diagnosis faster, more accurate and more ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Cardiol Therapeutics recently announced positive data in the Journal of the American College of Cardiology (JACC). The ...

Cardiovascular disease remains the leading cause of death among women, yet it is often underdiagnosed due to atypical symptoms, said Dr. Robin Conley of Baptist ...

Kennesaw State University researcher Chen Zhao has earned the 2025 American Heart Association Institutional Research ...

Kennesaw State University researcher Chen Zhao has earned the 2025 American Heart Association Institutional Research Enhancement Award (AIREA) for his unique research on non-invasive blood flow ...

Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...